Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases. J. Med. Life Sci. [Internet]. 2025 Apr. 3 [cited 2025 Apr. 10];1(2):63-9. Available from: https://www.gbspress.com/index.php/JMLS/article/view/216